Terms: = Colorectal cancer AND SEPT9, PNUTL4, 10801, ENSG00000184640, MSF1, KIAA0991, AF17q25, MSF, SeptD1, SINT1
121 results:
1. Detecting colorectal cancer using genetic and epigenetic biomarkers: screening and diagnosis.
Rezkitha YAA; Panenggak NSR; Lusida MI; Rianda RV; Mahmudah I; Pradana AD; Uchida T; Miftahussurur M
J Med Life; 2024 Jan; 17(1):4-14. PubMed ID: 38737656
[TBL] [Abstract] [Full Text] [Related]
2. Circulating-tumour DNA methylation of HAND1 gene: a promising biomarker in early detection of colorectal cancer.
Shavali M; Moradi A; Tahmaseb M; Mohammadian K; Ganji SM
BMC Med Genomics; 2024 Apr; 17(1):117. PubMed ID: 38689296
[TBL] [Abstract] [Full Text] [Related]
3.
Laven-Law G; Kichenadasse G; Young GP; Symonds EL; Winter JM
Biomarkers; 2024 Jun; 29(4):194-204. PubMed ID: 38644767
[TBL] [Abstract] [Full Text] [Related]
4. Association of Methylenetetrahydrofolate Reductase rs1801133 Gene Polymorphism with cancer Risk and Septin 9 Methylation in Patients with colorectal cancer.
Huang Y; Su T; Duan Q; Wei X; Fan X; Wan J; Liu L; Dian Z; Zhang G; Sun Y; Zhou T; Xu Y
J Gastrointest Cancer; 2024 Jun; 55(2):778-786. PubMed ID: 38252186
[TBL] [Abstract] [Full Text] [Related]
5. A novel screening method of DNA methylation biomarkers helps to improve the detection of colorectal cancer and precancerous lesions.
Li Y; Li B; Jiang R; Liao L; Zheng C; Yuan J; Zeng L; Hu K; Zhang Y; Mei W; Hong Z; Xiao B; Kong L; Han K; Tang J; Jiang W; Pan Z; Zhang S; Ding P
Cancer Med; 2023 Nov; 12(21):20626-20638. PubMed ID: 37881109
[TBL] [Abstract] [Full Text] [Related]
6. Aberrant methylation scanning by quantitative DNA melting analysis with hybridization probes as exemplified by liquid biopsy of sept9 and HIST1H4F in colorectal cancer.
Botezatu IV; Kondratova VN; Stroganova AM; Dranko SL; Lichtenstein AV
Clin Chim Acta; 2023 Nov; 551():117591. PubMed ID: 37832390
[TBL] [Abstract] [Full Text] [Related]
7. Serum methylation of GALNT9, UPF3A, WARS, and LDB2 as noninvasive biomarkers for the early detection of colorectal cancer and advanced adenomas.
Gallardo-Gómez M; Rodríguez-Girondo M; Planell N; Moran S; Bujanda L; Etxart A; Castells A; Balaguer F; Jover R; Esteller M; Cubiella J; Gómez-Cabrero D; De Chiara L
Clin Epigenetics; 2023 Oct; 15(1):157. PubMed ID: 37794510
[TBL] [Abstract] [Full Text] [Related]
8. Evaluation of a Multi-Gene Methylation Blood-Test for the Detection of colorectal cancer.
Petit J; Carroll G; Williams H; Pockney P; Scott RJ
Med Sci (Basel); 2023 Sep; 11(3):. PubMed ID: 37755164
[TBL] [Abstract] [Full Text] [Related]
9. Combined sept9 and BMP3 methylation in plasma for colorectal cancer early detection and screening in a Brazilian population.
Lima AB; Dos Reis MB; Matsushita M; Dos Reis MT; de Oliveira MA; Reis RM; Guimarães DP
Cancer Med; 2023 Aug; 12(15):15854-15867. PubMed ID: 37338022
[TBL] [Abstract] [Full Text] [Related]
10. The Clinical Significance of Septin 9 and Colon cancer Specific Antigen-2 (CCSA-2) in colorectal cancer.
Abd El Kader L; Soliman AH; Salem SE; Akel SY; Ibrahim NH
Asian Pac J Cancer Prev; 2023 Mar; 24(3):1027-1036. PubMed ID: 36974558
[TBL] [Abstract] [Full Text] [Related]
11. sept9 Expression in Hepatic Nodules: An Immunohistochemical Study of Hepatocellular Neoplasm and Metastasis.
Kmeid M; Park YN; Chung T; Pacheco RR; Arslan ME; Lee H
Appl Immunohistochem Mol Morphol; 2023 May-Jun 01; 31(5):278-287. PubMed ID: 36867734
[TBL] [Abstract] [Full Text] [Related]
12. A simplified multiplex methylated DNA testing for early detection of colorectal cancer in stool DNA.
Dai Y; Zhao G; Yang J; Zhou X; Xiong S; Lu X; Gao L; Wu J; Xu Z; Fei S; Zheng M; Xu H
BMC Gastroenterol; 2022 Oct; 22(1):428. PubMed ID: 36203138
[TBL] [Abstract] [Full Text] [Related]
13. Magnetic Nanoparticle-Based Electrochemical Sensing Platform Using Ferrocene-Labelled Peptide Nucleic Acid for the Early Diagnosis of colorectal cancer.
Hanoglu SB; Man E; Harmanci D; Tozan Ruzgar S; Sanli S; Keles NA; Ayden A; Tuna BG; Duzgun O; Ozkan OF; Dogan S; Ghorbanizamani F; Moulahoum H; Guler Celik E; Evran S; Timur S
Biosensors (Basel); 2022 Sep; 12(9):. PubMed ID: 36140121
[TBL] [Abstract] [Full Text] [Related]
14. Circulating Methylated sept9 DNA Analyses to Predict Recurrence Risk and Adjuvant Chemotherapy Benefit in Stage II to III colorectal cancer.
Yuan Z; Wang S; Ni K; Zhan Y; Ma H; Liu X; Xin R; Zhou X; Liu Z; Zhao X; Yin X; Ping H; Liu Y; Wang W; Yan S; Han Q; Cui W; Zhang X; Zhang Q; Zhang C
Med Sci Monit; 2022 Sep; 28():e937757. PubMed ID: 36117308
[TBL] [Abstract] [Full Text] [Related]
15. Gastrointestinal Conditions: colorectal cancer Screening and Prevention.
Davis J; Kellerman R
FP Essent; 2022 May; 516():17-22. PubMed ID: 35507309
[TBL] [Abstract] [Full Text] [Related]
16. Distinct Performance of Methylated
Tang H; Ma X; Zhou L; Li W; Shu Y; Xu H; Li J; Wang F; Sun F; Duan Y
Genet Test Mol Biomarkers; 2022 Apr; 26(4):239-248. PubMed ID: 35481971
[No Abstract] [Full Text] [Related]
17. DNA methylation-based diagnostic, prognostic, and predictive biomarkers in colorectal cancer.
Müller D; Győrffy B
Biochim Biophys Acta Rev Cancer; 2022 May; 1877(3):188722. PubMed ID: 35307512
[TBL] [Abstract] [Full Text] [Related]
18. Methylation of FBN1, SPG20, ITF2, RUNX3, SNCA, MLH1, and sept9 genes in circulating cell-free DNA as biomarkers of colorectal cancer.
Alizadeh-Sedigh M; Fazeli MS; Mahmoodzadeh H; Sharif SB; Teimoori-Toolabi L
Cancer Biomark; 2022; 34(2):221-250. PubMed ID: 34957998
[TBL] [Abstract] [Full Text] [Related]
19. Promoter methylation-mediated repression of UNC5 receptors and the associated clinical significance in human colorectal cancer.
Dong D; Zhang R; Shao J; Zhang A; Wang Y; Zhou Y; Li Y
Clin Epigenetics; 2021 Dec; 13(1):225. PubMed ID: 34922605
[TBL] [Abstract] [Full Text] [Related]
20. Application of droplet digital polymerase chain reaction of plasma methylated septin 9 on detection and early monitoring of colorectal cancer.
Ma ZY; Chan CSY; Lau KS; Ng L; Cheng YY; Leung WK
Sci Rep; 2021 Dec; 11(1):23446. PubMed ID: 34873218
[TBL] [Abstract] [Full Text] [Related]
[Next]
